home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.160 +0.020 (+1.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Don’t Confuse Bionano Genomics As an Investment Right Now ↗

May 03, 2021

The science underlining BNGO stock is incredibly compelling. But that’s not what the market actually cares about right now.

Via InvestorPlace

Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around ↗

April 30, 2021

It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 27, 2021

Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million...

Via Benzinga

Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today ↗

April 27, 2021

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano...

Via Benzinga

What's Going On With Bionano Genomics Stock Today? ↗

April 26, 2021

BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Mon...

Via Benzinga

58 Biggest Movers From Yesterday ↗

April 27, 2021

Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 26, 2021

Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of...

Via Benzinga

Bionano’s UK Deal Is Huge for BNGO Stock ↗

April 23, 2021

Bionano's deal with the UK's National Health Service validates the company's Saphyr system and puts it on the road to becoming a global powerhouse

Via InvestorPlace

Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025

April 23, 2021

Via FinancialNewsMedia

Is Bionano Genomics a Buy? ↗

April 23, 2021

Can you count on this company's novel gene diagnostic technology?

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 22, 2021

Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The market value of their outstanding shares is at $1.0...

Via Benzinga

Topics Artificial Intelligence

20 Stocks Moving in Thursday's Pre-Market Session ↗

April 22, 2021

Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:...

Via Benzinga

2 Biopharma Stocks That Look Ready For A Bullish Reversal ↗

April 21, 2021

Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wednesday. Ocugen is moving after its partner Bharat Biotech announced...

Via Benzinga

Why Bionano Genomics, Ocugen Are Rallying Today ↗

April 21, 2021

Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. Bionano Gains On Adoption of Genomic Mapping System By U....

Via Benzinga

Should You Buy Bionano Genomics in April? ↗

April 18, 2021

This stock market mover's growth story is just beginning.

Via The Motley Fool

Why Bionano Genomics Stock Is Tumbling Today ↗

April 16, 2021

No news; just run-of-the-mill volatility.

Via The Motley Fool

Bionano Genomics Stock Is Too Wild for Its Own Good ↗

April 09, 2021

BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment.

Via InvestorPlace

Bionano Genomics Stock Has Huge Potential, But It’s Very Risky ↗

April 09, 2021

BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com